The effects of 17α-E2 on SCD1 expression in activated HSCs were unanticipated and provides additional evidence that 17α-E2 almost certainly curtails mechanisms of liver disease through direct actions in HSCs, which is suggestive of ERβ-dependency48,49. This evidence concerns the gene SCD and liver disorder.